PCI Registry Basel
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This registry aims to learn more about the best ways to treat coronary artery disease. Information from routine medical care will be collected to compare different treatment approaches, including drug-eluting stents, drug-coated balloons (DCB), and bioresorbable scaffolds (BRS), which gradually dissolve over time. The registry will include people with coronary artery disease who receive an intervention (percutaneous coronary intervention), including those undergoing more complex procedures. By studying treatment outcomes over time, the Registry aims to better understand which therapies work best for different groups of patients and to improve future care for people with coronary artery disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing complex PCI (e.g. left main, bifurcation, multivessel PCI, rotational atherectomy or other calcium modification, complex anatomy). The definition complex will be a clinical/ procedural/ anatomical definition made by the operator.
Undergoing CTO or CHIP (Complex High-risk Indicated Patient) procedures
Treated with a DCB strategy
Treated with a BRS
Disqualifiers
Patients under 18 years of age
Trial population
The study population consits of patients undergoing percutaneous coronary interventions (PCI) at the University Hospital Basel
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Target Vessel Failure (TVF)
Composite endpoint defined as the occurrence of cardiovascular death, target vessel myocardial infarction, or unplanned target vessel revascularisation.
Time frame
Through study completion, an average of 1 yearOther outcomes
1
All-Cause Mortality
Death from any cause as documented in the available medical records.
Time frame
Through study completion, an average of 1 year2
Cardiovascular Mortality
Death attributed to a cardiovascular cause as documented in the medical records.
Time frame
Through study completion, an average of 1 year3
Occurrence of Myocardial Infarction
Documented occurrence of myocardial infarction in the medical records.
Time frame
Through study completion, an average of 1 year4
Procedural Success Rate
Proportion of PCI procedures meeting the predefined criteria for procedural success.
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov